公开(公告)号：US20180244771A1

公开(公告)日：2018-08-30

申请号：US15757452

申请日：2016-09-02

Applicant: ONO PHARMACEUTICAL CO., LTD.

Inventor： Shiro SHIBAYAMA ,  Hiroshi ARIMA ,  Takuya SIMBO

IPC: C07K16/28 ,  A61P35/02

CPC classification number: C07K16/283 ,  A01K67/0276 ,  A01K2207/12 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/0331 ,  A61K38/00 ,  A61K39/3955 ,  A61K45/00 ,  A61K45/06 ,  A61K2039/505 ,  A61K2300/00 ,  A61P35/02 ,  C07K16/2812 ,  C07K16/2818 ,  C07K2319/75

Abstract: A method for suppression of progress of, suppression of recurrence of and/or treatment of cancer, by administering an Allergin-1 antagonist in a therapy of a cancer patient with insufficient therapeutic efficacy by a tumor immunotherapeutic agent, or a cancer therapy in combination with an anti-cancer drug.

公开(公告)号：US20230256054A1

公开(公告)日：2023-08-17

申请号：US18183878

申请日：2023-03-14

Applicant: ONO PHARMACEUTICAL CO., LTD.

Inventor： Shiro SHIBAYAMA ,  Hiroshi ARIMA ,  Takuya SIMBO

IPC: A61K38/17 ,  A61K45/06 ,  A61K38/00 ,  A61K45/00 ,  A01K67/027 ,  A61P35/02 ,  C07K16/28

CPC classification number: A61K38/177 ,  A61K45/06 ,  A61K38/00 ,  A61K45/00 ,  A01K67/0276 ,  A61P35/02 ,  C07K16/283 ,  A61K2039/505

Abstract: A method for suppression of progress of, suppression of recurrence of and/or treatment of cancer includes administering an Allergin-1 antagonist in a therapy of a cancer patient with insufficient therapeutic efficacy by a tumor immunotherapeutic agent, or a cancer therapy in combination with an anti-cancer drug.